Učitavanje...
Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology
Currently, oncology testing includes molecular studies and cytogenetic analysis to detect genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid analysis of multiple genes for clinically actionable somatic variants. The WUCaMP assay uses targeted capture for NGS...
Spremljeno u:
| Izdano u: | J Mol Diagn |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Investigative Pathology
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5762937/ https://ncbi.nlm.nih.gov/pubmed/24211365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2013.10.002 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|